AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AMATI AIM VCT PLC

Director's Dealing Aug 15, 2019

4808_dirs_2019-08-15_940c6023-1f08-476f-9cce-c24c910276d1.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1935J

Amati AIM VCT PLC

15 August 2019

Transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

DR PAUL JOURDAN

2

Reason for the notification

a)

Position/status

INVESTMENT MANAGER

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

AMATI AIM VCT PLC

b)

LEI

213800HAEDBBK9RWCD25

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ORDINARY SHARES OF 5P EACH

ISIN: GB00B641BB82

b)

Nature of the transaction

SALE

c)

Price(s) and volume(s)

Price(s) Volume(s)
137.06P PER SHARE 131,961 ORDINARY SHARES OF 5P EACH

d)

Aggregated information

- Aggregated volume

- Price

131,961 ORDINARY SHARES OF 5P EACH

137.06P PER SHARE

e)

Date of the transaction

14/08/2019

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHSFESUIFUSEIA

Talk to a Data Expert

Have a question? We'll get back to you promptly.